Organigram's receipt of the Second Tranche will notably impact its financial standing, providing a significant cash infusion that underpins the company?s capital expenditure and strategic initiatives. This timely financing will support Organigram?s capacity expansion programs, including advancements in cultivation techniques, extraction technologies, and new product lines. Moreover, it will reinforce the company's balance sheet, facilitating sustainable growth and operational resilience against market volatilities.